These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6831503)

  • 1. [Treatment of hyperlipoproteinemia with lipanthyl].
    Kalinová M; Zadák Z; Sobotka L
    Cas Lek Cesk; 1983 Feb; 122(7):205-8. PubMed ID: 6831503
    [No Abstract]   [Full Text] [Related]  

  • 2. [Etolip and Lipanthyl in the treatment of hyperlipoproteinemia].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Vnitr Lek; 1990 Apr; 36(4):363-7. PubMed ID: 2356612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of lipanthyl in hyperlipoproteinaemic diabetic patients.
    Hajós P; Tornyossi M
    Ther Hung; 1989; 37(3):138-43. PubMed ID: 2588196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of fenofibrate on the lipid level in diabetic patients].
    Häring HU; Schleicher E; Renner R; Mehnert H
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):751-3. PubMed ID: 6415427
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of fenofibrate in various types of hyperlipoproteinemias].
    Sucić M
    Lijec Vjesn; 1989 Mar; 111(3):93-7. PubMed ID: 2747411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative research on etofibrate retard and fenofibrate in hyperlipoproteinemia].
    Schwartzkopff W; Schilling A
    Med Welt; 1980 Dec; 31(50):1845-50. PubMed ID: 7464535
    [No Abstract]   [Full Text] [Related]  

  • 7. [Procetofen in the treatment of hyperlipoproteinaemias (author's transl)].
    Micheli H; Pometta D
    Schweiz Rundsch Med Prax; 1980 Jan; 69(2):42-6. PubMed ID: 7367386
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of the effects of fenofibrate administered in doses of 3 x 100mg and 1 x 250mg per day in patients with type IIA, IIB and IV hyperlipoproteinemias].
    Reiner Z; Salzer B; Kes P
    Acta Med Iugosl; 1988; 42(5):353-62. PubMed ID: 3245481
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of procetofen on the lipoprotein profile in patients with type II hyperlipoproteinemia].
    Drouin P; Méjean L; Lambert D; Sauvanet JP; Debry G
    Med Welt; 1979 Dec; 30(50):1910-3. PubMed ID: 548697
    [No Abstract]   [Full Text] [Related]  

  • 10. Pantethine versus fenofibrate in the treatment of type II hyperlipoproteinemia.
    Postiglione A; Rubba P; Cicerano U; Chierchia I; Mancini M
    Monogr Atheroscler; 1985; 13():145-8. PubMed ID: 3911056
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of lipanthyl on parameters of lipid metabolism in patients with primary hyperlipoproteinemia].
    Sznajd J; Magdoń M; Idzior B; Konarska R; Malczewska M; Czarnecka H
    Przegl Lek; 1984; 41(2):217-21. PubMed ID: 6377392
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fenofibrate, efficacy and tolerance in long-term treatment (author's transl)].
    Fromantin M; Gautier D; Quatre JM; Bon R
    Therapie; 1981; 36(4):473-6. PubMed ID: 7292431
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of lipanthyl therapy on hyperlipoproteinemia type II/a, II/b and IV].
    Karádi I; Pados G; Németh-Csóka M; Romics L
    Orv Hetil; 1988 Aug; 129(33):1757-60. PubMed ID: 3174116
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)].
    Micheli H; Pometta D; Gustafson A
    Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of procetofen on lipoproteins and blood lipids in patients with hyperlipemia].
    Abaurre R; Vega J; Maneschi E; Bernabe H
    Medicina (B Aires); 1980; 40(6 Pt 2):896. PubMed ID: 7219169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Experience with the hypolipidemic drug Lipanthyl].
    Vaverková H; Kubasta M; Zmeskal A; Vrublovský P; Skrabalová H; Vlcek L
    Vnitr Lek; 1982 Jul; 28(7):698-704. PubMed ID: 7051538
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of bezafibrate and fenofibrate on elevated blood lipids in HLP type IIa, IIb and IV].
    Schwartzkopff W; Luley C; Scheffler W; Lehmann-Leo W; Schilling A; Wegscheider K
    Med Welt; 1982 Apr; 33(17):631-7. PubMed ID: 7098826
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C; Heller F; Desager JP
    Artery; 1980; 7(1):73-82. PubMed ID: 7247733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fenofibrate: hypolipaemic activity and safety in long-term treatment. Effects on HDL, LDL, VLDL and apoprotein B in short-term treatment (author's transl)].
    Rouffy J; Sauvanet JP; Chanu B; Bakir R; Goy-Loeper J; Saya C; Pinaroli F
    Nouv Presse Med; 1980 Dec; 9(49):3747-51. PubMed ID: 7208341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of clofibrate therapy on serum lipids and lipoproteins].
    Romics L; Szondy E; Gerö S
    Orv Hetil; 1980 Feb; 121(6):321-3. PubMed ID: 7366989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.